Bide Pharmatech Co., Ltd. (SHA:688073)
China
· Delayed Price · Currency is CNY 59.73
+1.68 (2.89%)
Apr 29, 2026, 4:00 PM EDT
Bide Pharmatech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | 151.74 | 117.43 | 109.57 | 145.97 | 97.57 | Upgrade
|
| Depreciation & Amortization | 30.37 | 28.43 | 26.93 | 17.61 | 10.67 | Upgrade
|
| Other Amortization | 9.38 | 15.25 | 14.16 | 8.62 | 7.47 | Upgrade
|
| Loss (Gain) From Sale of Assets | -3.9 | -0.86 | -0.44 | - | -7.92 | Upgrade
|
| Asset Writedown & Restructuring Costs | 39.54 | 0.03 | 0 | 0 | 0.04 | Upgrade
|
| Loss (Gain) From Sale of Investments | -7.98 | -5.98 | 8.87 | 0.4 | -0.41 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 1.75 | 4.33 | 3.52 | 3.06 | Upgrade
|
| Other Operating Activities | 17.18 | 41.23 | 20.11 | -5.92 | 11.97 | Upgrade
|
| Change in Accounts Receivable | -29.76 | 10.05 | -45.02 | -74.5 | -58.02 | Upgrade
|
| Change in Inventory | -231.94 | -96.65 | -196.27 | -52.81 | -267.2 | Upgrade
|
| Change in Accounts Payable | 24.94 | 43.2 | -1.58 | -14.89 | 134.92 | Upgrade
|
| Change in Other Net Operating Assets | 33.51 | 1.69 | 12.32 | - | 1.99 | Upgrade
|
| Operating Cash Flow | 28.32 | 158.31 | -57.39 | 29.87 | -64.88 | Upgrade
|
| Operating Cash Flow Growth | -82.11% | - | - | - | - | Upgrade
|
| Capital Expenditures | -24.28 | -88.35 | -61.08 | -38.41 | -29.2 | Upgrade
|
| Sale of Property, Plant & Equipment | 10.05 | 2.2 | 0.93 | - | 15.15 | Upgrade
|
| Cash Acquisitions | -7.02 | - | - | - | - | Upgrade
|
| Investment in Securities | -54.78 | -77.92 | - | 0.59 | 43.41 | Upgrade
|
| Other Investing Activities | 0.88 | 5.59 | 4.06 | -4.79 | - | Upgrade
|
| Investing Cash Flow | -75.15 | -158.48 | -28.87 | -42.61 | 29.36 | Upgrade
|
| Short-Term Debt Issued | - | 97.35 | 0.23 | - | 20.73 | Upgrade
|
| Long-Term Debt Issued | 250.71 | 5.6 | 4.98 | 9.61 | - | Upgrade
|
| Total Debt Issued | 250.71 | 102.94 | 5.21 | 9.61 | 20.73 | Upgrade
|
| Short-Term Debt Repaid | - | -68.01 | -9.53 | - | -37.69 | Upgrade
|
| Long-Term Debt Repaid | -194.28 | -21.88 | -21.83 | -13.89 | -8.53 | Upgrade
|
| Total Debt Repaid | -194.28 | -89.89 | -31.36 | -13.89 | -46.22 | Upgrade
|
| Net Debt Issued (Repaid) | 56.43 | 13.06 | -26.14 | -4.28 | -25.49 | Upgrade
|
| Issuance of Common Stock | - | - | - | 1,335 | 163.9 | Upgrade
|
| Repurchase of Common Stock | - | -100.02 | - | - | - | Upgrade
|
| Common Dividends Paid | -79.79 | -79.88 | -100.03 | -0.08 | -0.19 | Upgrade
|
| Other Financing Activities | -114.68 | - | -12.13 | -20.52 | -0.77 | Upgrade
|
| Financing Cash Flow | -138.04 | -166.84 | -138.31 | 1,310 | 137.44 | Upgrade
|
| Foreign Exchange Rate Adjustments | -8.77 | -1.44 | -5.83 | 4.73 | -0.3 | Upgrade
|
| Net Cash Flow | -193.63 | -168.45 | -230.39 | 1,302 | 101.62 | Upgrade
|
| Free Cash Flow | 4.04 | 69.97 | -118.47 | -8.54 | -94.09 | Upgrade
|
| Free Cash Flow Growth | -94.23% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 0.30% | 6.35% | -10.85% | -1.02% | -15.52% | Upgrade
|
| Free Cash Flow Per Share | 0.05 | 0.79 | -1.31 | -0.12 | -1.41 | Upgrade
|
| Cash Income Tax Paid | 14.35 | 19.77 | 2.5 | 25.48 | 12.74 | Upgrade
|
| Levered Free Cash Flow | -48.17 | 26.94 | -188.91 | -43.78 | -120.54 | Upgrade
|
| Unlevered Free Cash Flow | -48.17 | 29.01 | -187.33 | -42.42 | -119.96 | Upgrade
|
| Change in Working Capital | -208 | -38.96 | -240.92 | -140.34 | -187.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.